New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHGH Fragment 176-191 vs Triptorelin

HGH Fragment 176-191 vs Triptorelin

Side-by-side comparison of key properties, dosing, and research.

Fat Loss & Metabolic
HGH Fragment 176-191
Sexual Health & Libido
Triptorelin
Summary
HGH Fragment 176-191 (also known as AOD-9604) is a stabilized, modified fragment of the human growth hormone molecule corresponding to amino acids 176–191 with an addition of a tyrosine residue at the N-terminus. It retains HGH's fat-burning properties without the anabolic, diabetogenic, or IGF-1-stimulating effects.
Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH) with 100x the potency of native GnRH. An FDA-approved drug (Trelstar) for prostate cancer and precocious puberty, it is also used in post-cycle therapy (PCT) to rapidly restart the hypothalamic-pituitary-gonadal (HPG) axis after anabolic steroid suppression.
Half-Life
~30 minutes
Depot forms: weeks to months; aqueous: 6-8 hours
Admin Route
SubQ
SubQ, IM
Research
Typical Dose
250–500 mcg
100 mcg
Frequency
1–3 times daily
Single injection
Key Benefits
  • Selective fat burning without anabolic side effects
  • Reduces visceral and subcutaneous fat
  • No insulin resistance or blood glucose disruption
  • Does not stimulate IGF-1
  • May support cartilage and bone repair (at higher doses)
  • No effect on growth or organ size
  • Rapid HPG axis restart after steroid use
  • Single-injection PCT protocol possible
  • Massively elevates LH and FSH via flare effect
  • Restores endogenous testosterone faster than traditional PCT
  • FDA-approved for established medical uses
Side Effects
  • Injection site irritation
  • Temporary lethargy
  • Headache (rare)
  • Nausea (rare)
  • Initial testosterone flare (intended)
  • Injection site reactions
  • Hot flashes (with chronic use)
  • Decreased libido (chronic dosing)
Stacks With